NK Cell Therapy and Stem Cell Therapy Market 2020 Industry Growth, Size, Trends, Share, Opportunities and Forecast to 2026 – Red & Black Student…

Global NK Cell Therapy and Stem Cell Therapy Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread) Report Overview

The global NK Cell Therapy and Stem Cell Therapy Market report has been compiled after extensive market research into various parameters concerning the NK Cell Therapy and Stem Cell Therapy Market industry. An overview of the market and the market share of the different segments that the NK Cell Therapy and Stem Cell Therapy Market is categorized into is presented. The scope of growth of the different products/services offered by different manufacturers in the NK Cell Therapy and Stem Cell Therapy Market industry has been discussed in detail and the results have been included in the report. The market share that the global NK Cell Therapy and Stem Cell Therapy Market occupies is presented from the year 2020 to the year 2026 comprising the base period.

Key Players:-

Chipscreen BiosciencesInnate Pharma SAOsiris TherapeuticsChiesi PharmaceuticalsMolmedJCR PharmaceuticalAltor BioScience Corporation

The global NK Cell Therapy and Stem Cell Therapy Market has several companies that are involved in it. These different companies are analyzed to identify the companies/organizations that occupy a large chunk of the market share. Once the identification process is completed the strategic profiling is carried out. This includes the revenue that each company has earned from the year 2020 to the year 2026 during the base period. As a result of this data, the growth of the different companies can be accurately predicted for the forecast period from the year 2020 to the year 2026 in detail.

Get Free Sample Copy of the Report of NK Cell Therapy and Stem Cell Therapy Market@ https://www.algororeports.com/sample-request/nk-cell-therapy-and-stem-cell-therapy-market-research-report-trends-one-2940079?utm_source=redandblackonline&utm_medium=53

Regional Scope of the NK Cell Therapy and Stem Cell Therapy Market:

North America (Covered in Chapter 6 and 13)United StatesCanadaMexicoEurope (Covered in Chapter 7 and 13)GermanyUKFranceItalySpainRussiaOthersAsia-Pacific (Covered in Chapter 8 and 13)ChinaJapanSouth KoreaAustraliaIndiaSoutheast AsiaOthersMiddle East and Africa (Covered in Chapter 9 and 13)Saudi ArabiaUAEEgyptNigeriaSouth AfricaOthersSouth America (Covered in Chapter 10 and 13)BrazilArgentinaColumbiaChileOthers

What questions does the NK Cell Therapy and Stem Cell Therapy Market report answer pertaining to the regional reach of the industry?

Which among these regions has been touted to amass the largest market share over the anticipated duration

How do the sales figures look at present how does the sales scenario look for the future?

Considering the present scenario, how much revenue will each region attain by the end of the forecast period?

How much is the market share that each of these regions has accumulated presently

How much is the growth rate that each topography will depict over the predicted timeline

Reasons to Read this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Research Methodology of NK Cell Therapy and Stem Cell Therapy Market:-

The data that is presented in the NK Cell Therapy and Stem Cell Therapy Market report is analyzed and verified to ensure that it is free from errors and discrepancies that may have occurred during the collection. One of the primary analysis methods used is Porters Five Forces Model. It uses five distinct parameters to analyze the collected data that include the threat of substitutes, the bargaining power of customers, the threat of new entrants, the bargaining power of suppliers and competitive rivalry. The analyzed data is then presented in the NK Cell Therapy and Stem Cell Therapy Market report.

The final report will add the analysis on NK Cell Therapy and Stem Cell Therapy Market Industry.

The report scrutinizes different business approaches and frameworks that pave the way for success in businesses. The report used Porters five techniques for analyzing the NK Cell Therapy and Stem Cell Therapy Market; it also offers the examination of the global market. To make the report more potent and easy to understand, it consists of info graphics and diagrams. Furthermore, it has different policies and improvement plans which are presented in summary. It analyzes the technical barriers, other issues, and cost-effectiveness affecting the market.

Reasons to Read this Report:-

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

TABLE OF CONTENT:

Chapter 1: Plug-in NK Cell Therapy and Stem Cell Therapy Market Research Scope.

Chapter 3: Plug-in NK Cell Therapy and Stem Cell Therapy Market Competition by Manufacturers

Chapter 4: Global Production, Revenue (Value) by Region

Chapter 5: Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6: Global Production, Revenue (Value), Price Trend by Type

Chapter 7: Global Market Analysis by Application

Chapter 8: Manufacturing Cost Analysis

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Plug-in NK Cell Therapy and Stem Cell Therapy Market Factors Analysis

Chapter 12: GlobalPlug-in NK Cell Therapy and Stem Cell Therapy Market Forecast to 2026

Enquiry to Buy This Report: https://www.algororeports.com/enquiry/nk-cell-therapy-and-stem-cell-therapy-market-research-report-trends-one-2940079?utm_source=redandblackonline&utm_medium=53

About Us:

AlgoroReportsis one of the most significant databases of online market researches and intelligence reports and services. The online portal for marketing research deals with access to global market data and assists in providing expert insights and exposure on global companies, industries, products and trends. AlgoroReports Consists of a highly motivated team of young and experienced individual focused on providing clients expert information they need.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

Ph: +1-352-353-0818 (US)

Website: https://www.algororeports.com/

Read more:

NK Cell Therapy and Stem Cell Therapy Market 2020 Industry Growth, Size, Trends, Share, Opportunities and Forecast to 2026 - Red & Black Student...

Read more
Stem Cell Banking Market : Facts, Figures and Analytical Insights 2020 2029 – Scientect

The research study on Global Stem Cell Banking market 2019 presents an extensive analysis of current Stem Cell Banking market size, drivers, trends, opportunities, challenges, as well as key Stem Cell Banking market segments. Further, it explains various definitions and classification of the Stem Cell Banking industry, applications, and chain structure.In continuation of this data, the Stem Cell Banking report covers various marketing strategies followed by key players and distributors. Also explains Stem Cell Banking marketing channels, potential buyers and development history. The intent of global Stem Cell Banking research report is to depict the information to the user regarding Stem Cell Banking market forecast and dynamics for the upcoming years. The Stem Cell Banking study lists the essential elements which influence the growth of Stem Cell Banking industry. Long-term evaluation of the worldwide Stem Cell Banking market share from diverse countries and regions is roofed within the Stem Cell Banking report. Additionally, includes Stem Cell Banking type wise and application wise consumption figures.

The Final Report will cover the impact analysis of COVID-19 on this industry.

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10225616

After the basic information, the global Stem Cell Banking Market study sheds light on the Stem Cell Banking technological evolution, tie-ups, acquisition, innovative Stem Cell Banking business approach, new launches and Stem Cell Banking revenue. In addition, the Stem Cell Banking industry growth in distinct regions and Stem Cell Banking R;D status are enclosed within the report.The Stem Cell Banking study also incorporates new investment feasibility analysis of Stem Cell Banking. Together with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities, and challenges in the Stem Cell Banking market.

Global Stem Cell Banking Market Segmentation 2019: Stem Cell BankingThe study also classifies the entire Stem Cell Banking market on basis of leading manufacturers, different types, various applications and diverse geographical regions. Overall Stem Cell Banking market is characterized by the existence of well-known global and regional Stem Cell Banking vendors. These established Stem Cell Banking players have huge essential resources and funds for Stem Cell Banking research as well as developmental activities. Also, the Stem Cell Banking manufacturers focusing on the development of new Stem Cell Banking technologies and feedstock. In fact, this will enhance the competitive scenario of the Stem Cell Banking industry.

The Leading Players involved in global Stem Cell Banking market are:

By Source Type (Cord Blood and Cord Tissue),

By Service Type (Collection and Transportation, Processing, Analysis, and Storage)

By Application (Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia, and Others)

By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10225616

Worldwide Stem Cell Banking Market Different Analysis:Competitors Review of Stem Cell Banking Market: Report presents the competitive landscape scenario seen among top Stem Cell Banking players, their company profile, revenue, sales, business tactics and forecast Stem Cell Banking industry situations. Production Review of Stem Cell Banking Market: It illustrates the production volume, capacity with respect to major Stem Cell Banking regions, application, type, and the price. Sales Margin and Revenue Accumulation Review of Stem Cell Banking Market: Eventually explains sales margin and revenue accumulation based on key regions, price, revenue, and Stem Cell Banking target consumer. Supply and Demand Review of Stem Cell Banking Market: Coupled with sales margin, the report depicts the supply and demand seen in major regions, among key players and for every Stem Cell Banking product type. Also interprets the Stem Cell Banking import/export scenario. Other key reviews of Stem Cell Banking Market: Apart from the above information, correspondingly covers the company website, number of employees, contact details of major Stem Cell Banking players, potential consumers and suppliers. Also, the strengths, opportunities, Stem Cell Banking market driving forces and market restraints are studied in this report.

Highlights of Global Stem Cell Banking Market Report:* This report provides in detail analysis of the Stem Cell Banking and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2019 ; 2029. * It also elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for world Stem Cell Banking market. * This study also provides key insights about Stem Cell Banking market drivers, restraints, opportunities, new product launches, approvals, regional outlook, and competitive strategies adopted by the leading Stem Cell Banking players. * It profiles leading players in the worldwide Stem Cell Banking market based on the following parameters ; company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans. * Insights from Stem Cell Banking report would allow marketers and management authorities of companies to make an informed decision with respect to their future product launches, market expansion, and Stem Cell Banking marketing tactics. * The world Stem Cell Banking industry report caters to various stakeholders in Stem Cell Banking market. That includes investors, device manufacturers, distributors and suppliers for Stem Cell Banking equipment. Especially incorporates government organizations, Stem Cell Banking research and consulting firms, new entrants, and financial analysts. *Various strategy matrices used in analyzing the Stem Cell Banking market would provide stakeholders vital inputs to make strategic decisions accordingly.

Global Stem Cell Banking Market Report Provides Comprehensive Analysis of Following: ; Stem Cell Banking Market segments and sub-segments ; Industry size ; Stem Cell Banking shares ; Stem Cell Banking Market trends and dynamics ; Market Drivers and Stem Cell Banking Opportunities ; Supply and demand of world Stem Cell Banking industry ; Technological inventions in Stem Cell Banking trade ; Stem Cell Banking Marketing Channel Development Trend ; Global Stem Cell Banking Industry Positioning ; Pricing and Brand Strategy ; Distributors/Traders List enclosed in Positioning Stem Cell Banking Market.

Request For Full Report:https://www.kennethresearch.com/sample-request-10225616

Moreover, the report organizes to provide essential information on current and future Stem Cell Banking market movements, organizational needs and Stem Cell Banking industrial innovations. Additionally, the complete Stem Cell Banking report helps the new aspirants to inspect the forthcoming opportunities in the Stem Cell Banking industry. Investors will get a clear idea of the dominant Stem Cell Banking players and their future forecasts.

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products demand, growth and opportunities for new and existing players.

Contact Us

Kenneth ResearchEmail: [emailprotected]Phone: +1 313 462 0609

See the article here:

Stem Cell Banking Market : Facts, Figures and Analytical Insights 2020 2029 - Scientect

Read more
Impact of Radiation Therapy on Survivors of Pediatric Abdominal and Pelvic Tumors – Cancer Network

A study published in Cancer Epidemiology, Biomarkers & Prevention suggested that among survivors of childhood abdominal or pelvic tumors, abdominal or pelvic radiotherapy is associated with body composition changes that can adversely influence metabolic outcomes and performance status.1

The impacts of radiation therapy on metabolic health have previously been reported for survivors of pediatric leukemia, brain tumors, and hematopoietic stem cell transplants, according to Carmen Wilson, PhD, assistant member in the Epidemiology and Cancer Control department at St. Jude Childrens Research Hospital, though the impacts on survivors of pediatric abdominal and pelvic tumors were unclear.2

Body composition abnormalities and cardiometabolic impairments are of concern among survivors given that in the general population, these conditions increase the risk of developing life-threatening diseases including cardiovascular disease and type 2 diabetes, Wilson said in a press release.

In total, the study cohort included 431 survivors of abdominal or pelvic tumors. Relative lean mass and fat mass were assessed in participants using dual X-ray absorptiometry and metabolic outcomes, including insulin resistance, high-density lipoprotein, low-density lipoprotein, and triglycerides, were based on laboratory values and medication usage.

Lean mass was found to be lower than values from the National Health and Nutrition Examination Survey (NHANES) in both males (Z-score = -0.67 1.27; P < .001) and females (Z-score = -0.72 1.28; P < .001). Higher cumulative abdominal and pelvic radiation doses were also associated with lower lean mass among males (abdominal: b = -0.22 [SE] 0.07; P = .002 and pelvic: b = -0.23 0.07; P = .002) and females (abdominal: b = -0.30 0.09; P = .001 and pelvic: b = -0.16 0.08; P = .037).

Collectively, ours and others data suggest that survivors may be at risk of developing diabetes through multiple pathways, either from direct damage to the pancreas following radiotherapy, and following [insulin resistance] as a result of alterations in function and secretions of adipocytes and from increased adiposity, the authors explained.

Moreover, the prevalence of insulin resistance (40.6% vs. 33.8%; P = .006), low HDL (28.9% vs. 33.5%; P = .046), and high triglycerides (18.4% vs. 10.0%; P < .001) was increased among survivors relative to NHANES. Compared with survivors with normal to high lean mass and normal to low fat mass, those with normal to high lean mass and high fat mass had an increased risk of insulin resistance (P < .001), low HDL (P < .001), reduced quadriceps strength at 60 per second (P < .001) and 300 per second (P < .001), and reduced distance covered in a 6-minute walk (P < .01).

High adiposity and associated reductions in strength, mobility, and flexibility among survivors are of concern because these measures are markers of physical fitness; higher levels of fitness are associated with decreased risk of cardiovascular disease, hypertension, and noninsulin-dependent diabetes mellitus in the general population, the authors noted.

Notably, given that the researchers used data from NHANES for comparisons of prevalence, differences in the measurement of cardiometabolic outcomes among the survivor cohort and NHANES may have adversely influenced comparisons of prevalence. Even further, though the investigators were unable to examine the influence of abdominal or pelvic surgeries on functional performance among survivors, survivors with serious, severe, or disabling chronic musculoskeletal and neurologic conditions were excluded from analyses.

Moving forward, though it may not be possible to avoid radiotherapy as a key treatment for many solid tumors, the researchers suggested that further research is required to evaluate whether interventions in both child- and adulthood could meliorate abnormalities in body composition and cardiometabolic impairments. In addition, Wilson suggested she is interested in exploring how interventions directed at lifestyle behaviors could improve lean mass and decrease fat mass among survivors of pediatric cancers.

While it may not be possible to avoid radiation therapy as a key treatment for many solid tumors, early research suggests that resistance training interventions in survivors increase lean mass, said Wilson. Further work is needed to see if training would also impact cardiometabolic impairments in this population.

References:

1. Wilson CL, Liu W, Chemaitilly W, et al. Body Composition, Metabolic Health, and Functional Impairment among Adults Treated for Abdominal and Pelvic Tumors during Childhood. Cancer Epidemiology, Biomarkers & Prevention 2020. doi: 10.1158/1055-9965.EPI-19-1321.

2. Radiation Therapy for the Treatment of Pediatric Cancers May Have Long-term Impacts on Cardiovascular and Metabolic Health [news release]. Published August 13, 2020. Accessed August 17, 2020.

See the article here:

Impact of Radiation Therapy on Survivors of Pediatric Abdominal and Pelvic Tumors - Cancer Network

Read more
Global Cell Isolation Technology Market 2020 Analysis, Types, Applications, Forecast and COVID-19 Impact Analysis 2025 – Scientect

MarketsandResearch.biz has published the latest market research study on Global Cell Isolation Technology Market 2020 by Company, Regions, Type and Application, Forecast to 2025 which investigates a few critical features of the market such as industry condition, division examination, market insights. The report studies the global Cell Isolation Technology market share, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels. The report has referenced down to earth ideas of the market in a straightforward and unassuming way in this report. The research contains the categorization of the market by top players/brands, region, type, and end-user. The report exhaustive essential investigation of current market trends, opportunities, challenges, and detailed competitive analysis of the industry players in the market.

The research report has comprehensively included numbers and figures with the help of graphical and pictorial representation which embodies more clarity on the global Cell Isolation Technology market. Then the report delivers key information about market players such as company overview, total revenue (financials), market potential, global presence, as well as market share, prices, production sites and facilities, products offered, and strategies adopted by them. Market status and outlook of global and major regions, from angles of players, countries, product types, and end industries have been analyzed.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/82010

Key strategic manufacturers included in this report: Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Merck, Stemcell Technologies, BD Biosciences, GE Healthcare, Terumo BCT

Market Potential:

Key market vendors have been predicted to obtain the latest opportunities as there has been an increased emphasis on spending more on the work of research and development by many of the manufacturing companies. Also, many of the market contenders are forecasted to make a foray into the emerging economies to find new opportunities. The global Cell Isolation Technology market has gone through rapid business transformation by good customer relationships, drastic and competitive growth, significant changes within the market, and technological advancement in this market.

Geographically, this report is segmented into several key countries, with market size, growth rate, import and export of in these countries from 2015 to 2020, which covering: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), MENA (Saudi Arabia, UAE, Turkey and South Africa)

The market can be segmented into product types as: Centrifugation, Flow Cytometry, Cell Electrophoresis

The market can be segmented into applications as: Stem cell research, Cancer research, Tissue regeneration, In-vitro diagnostics, Others

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/82010/global-cell-isolation-technology-market-2020-by-company-regions-type-and-application-forecast-to-2025

Reasons for Buying Market Report:

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]rch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for worlds leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: [emailprotected]Web: http://www.marketsandresearch.biz

Read more:

Global Cell Isolation Technology Market 2020 Analysis, Types, Applications, Forecast and COVID-19 Impact Analysis 2025 - Scientect

Read more
Mike Tyson reveals all after doctors gave him blood injection that left him feeling weird during stem cell t – The Irish Sun

MIKE TYSON has revealed he was injected with nearly-translucent blood in his bid to make a comeback... and the former heavyweight champ said it made him feel "weird".

The 54-year-old - who initially retired from boxing in 2005 - will fight Roy Jones Jr in November in his eagerly-anticipated comeback fight.

2

His return to action has been aided by stem-cell research therapy, which has left him feeling like a "different person".

In May, Tyson claimed: "You know what I had done? I had stem-cell research therapy.

"I feel like a different person but I can't comprehend why I feel this way.

"It's really wild what scientists can do."

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition that usually takes the form of a bone marrow transplantation.

Tyson opened up on the effects the treatment has had on him in an recent interview with rapper LL Cool J on the Rock the Bells Radio show on SiriusXM, earlier in 2020.

Commenting on the mental aspect of training for a fight for the first time in 15 years, he said: "My mind wouldnt belong to me.

"My mind would belong to somebody that disliked me enough to break my soul, and I would give them my mind for that period of time.

"Six weeks of this and Id be in the best shape Ive ever dreamed of being in. As a matter of fact, Im going through that process right now. And you know what else I did, I did stem-cell research."

Tyson was then asked whether that meant if his white blood had been spun and then put back in, to which he replied: "Yes. As they took the blood it was red and when it came back it was almost transfluid (sic).

"I could almost see through the blood, and then they injected it in me.

"And Ive been weird ever since, Ive got to get balanced now."

2

ROCKY STARDubois delighted Fury compared him to Drago.. even if he doesn't know who he is

Exclusive

BOIS POISEDDubois confident he can take over soon after shock KOs for Joshua and Whyte

HALl-MARKHow Eddie Hall is transforming into boxer for Thor fight with intense training

WEIGH TO GOConor Benn tips 'animal' Vergil Ortiz to surpass Spence and Crawford

NOT FINE WITH ITDelfine Persoon now claims she deserved to beat Katie Taylor

BROTHERLY GLOVETyson Fury tips Tommy to go 'all the way' as brothers share training vid

WHAT IS STEM CELL TREATMENT USED FOR?

Stem cell transplants are carried out when bone marrow is damaged or isnt able to produce healthy blood cells.

It can also be used to replace damaged blood cells as the result of intensive cancer treatment.

Here are conditions that stem cell transplants can be used to treat:

Iron Mike had been called out by former rival Evander Holyfield to complete their trilogy following their two meetings in 1990s.

But he has since looked elsewhere, taking on Jones Jr later this year - potentially in front of a packed house.

Tyson is looking in incredible condition, too as he continues this hard graft.

Read this article:

Mike Tyson reveals all after doctors gave him blood injection that left him feeling weird during stem cell t - The Irish Sun

Read more
First Woman May Be Cured of HIV Without a Bone Marrow Transplant – POZ

A California woman may be the first person to be cured of HIV without a bone marrow transplant, according to a recent report in Nature. More than 60 other so-called elite controllers, who have unusually potent immune responses to HIV, were found to have their virus sequestered in parts of their genome where it is unable to replicate.

The unusual case involves Loreen Willenberg, who acquired HIV in 1992. Her immune system has maintained control of the virus for decades without the use of antiretroviral treatment, and researchers have been unable to find any intact virus in more than 1.5 billion of her cells. Elite controllers are thought to make up less than half a percent of all people living with HIV.

I believe Loreen might indeed meet anyones definition of a cure, study coauthor Steven Deeks, MD, of the University of California at San Francisco, told POZ. Despite heroic efforts, we just could not find any virus that is able to replicate. Her immune system seems completely normal. Even her HIV antibodies levels are low, which is unprecedented in an untreated person.

Although antiretroviral therapy can keep HIV replication suppressed, the virus inserts its genetic material into the chromosomes of human cells, making it very difficult to eradicate. HIV can lie dormant in a reservoir of resting immune cells indefinitely, but when antiretrovirals are stopped and the cells become activated, they can start churning out new virus.

Previously, only two people were known to have been cured of HIV: Timothy Ray Brown, formerly know as the Berlin Patient, and a man in London. Both received bone marrow stem cell transplants from a donor with a rare genetic mutation that makes cells resistant to HIV entry. But this procedure is far too dangerous for people who dont need it to treat advanced cancer.

The new research suggests that Willenberg and some five dozen other people with long-term untreated HIV have their virus hidden away in their cells genomes in such as way that the viral genetic blueprint (known as a provirus) cant be used to produce new viral particles that can go on to infect other cells.

Xu Yu, MD, of the Ragon Institute of Massachusetts General Hospital, MIT and Harvard analyzed integrated HIV in millions of cells from 64 elite controllers and 41 typical HIV-positive people on antiretroviral therapy recruited at Mass General and San Francisco General Hospital.

In both groups, about 20% were women, the average age was approximately 56, they had been living with HIV for an average of 17 years and had undetectable virus according to standard tests for nine years. Overall, the elite controllers had a higher average CD4 count (about 900 versus 70, respectively).

The researchers used next-generation gene sequencing to characterize the participants viral blueprints, including where they were inserted into human chromosomes. They found that the elite controllers had fewer integrated proviruses, but a larger proportion of them were intact, or potentially capable of replicating. The virus in these individuals was highly consistent, without the wide variety of mutations seen in most people with HIV.

Whats more, their proviruses were integrated at distinct sites in the human genome, farther away from elements that enable viral replication. Specifically, the integrated DNA was not located near sites that switch on transcription or close to accessible chromatin, which contains histone proteins that package long DNA strands into a more compact form. The DNA must then be unwound from these proteins before it can be used to produce new virus.

These data suggest that a distinct configuration of the proviral reservoir represents a structural correlate of natural viral control, and that the quality, rather than the quantity, of viral reservoirs can be an important distinguishing feature for a functional cure of HIV-1 infection, Yu and colleagues wrote.

In a commentary accompanying the report, Nicolas Chomont, PhD, of the University of Montreal, characterized the proviruses in these elite controllers as being in a state of deep sleep compared with latent virus in typical people with HIV. This has only become apparent now because researchers have more sophisticated tools to pinpoint the location of proviruses within the genome.

It is unclear why this block and lock phenomenon happens in only a small proportion of people with HIV. Its possible that the virus ends up sequestered in these locations by chance. But the researchers think its more likely that the integrated proviruses at these sites are evolutionarily selected over time as the ones in locations more conducive to viral replication are eliminated by the immune system.

In Willenbergs case, the research team analyzed more than 1.5billion of her peripheral blood immune cells, including samples from gut tissue, where the virus often hides. Theycould not find any intact proviruses that could be used to produce new HIV. Given her absence of intact proviruses, the researcherswere unable to determine whether she ever fit the pattern of having latent HIV locked away in inaccessible locations.

Another 11 people, dubbed exceptional controllers, only had detectableprovirusesatremote sites in the genome where it could not replicate.Since this study, the researchers have discovered a couple more elite controllers who may qualify as additional cures, according to the New York Times.

This raises the possibility that a sterilizing cure of HIVmeaning complete eradicationmay be feasible in rare instances, the study authors suggested. A similar but less complete process may be at play in the subset of about 10% of people with HIV who maintain viral suppression after stopping antiretroviral therapy but who still have detectable proviruses (known as post-treatment controllers).

This research was first presented at the International AIDS Society Conference on HIV Science last summer, where Willenberg was referred to as the San Francisco Patient. Willenberg later went public with her status, and she and Yu discussed the study findings during a webinar with HIV cure advocates last November.

I broke out in tears when saw Dr. Yus final slide, said Willenberg, who over the years has participated in more than a dozen studies. I can only hope and pray that with continued dedication we can figure out how I have dumped the virus into the DNA junkyard.

The question now is whether its possible to develop treatments that could enable the millions of typical people with progressive HIV to become elite controllers like Willenberg. Chomont suggested that immune-based therapiesincluding CAR-T cellsmight be able to shrink the viral reservoir until it consists only of deeply latent proviruses that are unable to replicate.

The key question is how did her immune system achieve this remarkable state, Deeks said. We do not know. We need to find more people who are exceptional controllers like Loreen and get to work on figuring out the mechanism.

In this video fromamfAR, the Foundation for AIDS Research,Loreen Willenbergtalks about living as an elite controller of HIV.

Click here to read the Nature article.Click here for more news about HIV cure research.

Read more:

First Woman May Be Cured of HIV Without a Bone Marrow Transplant - POZ

Read more
Sterile Filtration Market To Reach USD 8.48 Billion By 2027 | CAGR: 7.7% | Reports And Data – PRNewswire

NEW YORK, Aug. 27, 2020 /PRNewswire/ --The GlobalSterile Filtration Marketis expected to reach USD 8.48 Billion by 2027, according to a new report by Reports and Data. Sterile filtration finds usage in the removal of contaminants and particulates from fluids comprising media with or without buffers, serum, reagents, biologic or proteinaceous samples, or other types of fluids. Filtration through a pore size of 0.2 m is essential to get a sterile filtrate by filtering particles and germs from fluids (liquids and gases) to prevent them from contaminating the end-products. As per the GMP guidelines and the guidelines by the (FDA), producers are required to perform a filter integrity test at the pre and post-production cycle. The test confirms that the filter is completely functional and that no undesirable components got through it.

Biopharmaceuticals products normally cannot be terminally sterilized, and thus it is crucial to use sterile grade filters in aseptic processing. Application of heat sterilization or any other process in biopharmaceutical drug products results in unwanted degradation of the product. Sterilizing membrane filtration frequently necessitated reducing the levels of bioburden within process streams to prevent the potential formation of biofilm. Further, to ascertain that the sterile filtered products uphold the pure form, a growing number of firms, especially the firms in the pharmaceutical sector, are deploying disposable process solutions to store or process the subsequent filtrate.

Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/3464

The growing use of sterile filtration in the food & beverage industry, especially in breweries, is playing an instrumental role in driving market growth. Recent researches uphold the use of sterile filtration as the most appropriate method for brewers for controlling microbial hazards. Even though beer is alcoholic, acidic, anaerobic, and comprises hop compounds that ply the role of preservatives, certain microorganisms can survive in the chemical environment and thrive on rich nutrients present in beer. These kinds of microorganisms may result in beer spoilage forming a haze or sedimentation, a rancid/sour flavor, and over-carbonation, thus requiring the need for sterile filtration.

COVID-19 Impact Analysis

As global economies are experiencing the negative impact of the Covid-19 pandemic, organizations are suffering losses, among various other challenges. Nevertheless, firms in the pharmaceutical industry are of immense importance in combatting the pandemic and are witnessing positive growth in the contagious disease landscape with the race for treatment approval therapy gaining momentum.

Biopharmaceutical companies are playing a significant role in human response to the COVID-19 pandemic. Various leading biotech companies are studying the genome to prepare a feasible vaccine for its treatment. Growing investments in R&D activities for making the vaccine are fuelling the growth of the sterile filtration market.

To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/sterile-filtration-market

Further key findings from the report suggest

Order Now: https://www.reportsanddata.com/checkout-form/3464

For the purpose of this report, Reports and Data has segmented the Global Sterile Filtration Market on the basis of type, membrane type, application, end-user, and region:

TypeOutlook (Revenue, USD Million; 2017-2027)

Membrane TypeOutlook (Revenue, USD Million; 2017-2027)

ApplicationOutlook (Revenue, USD Million; 2017-2027)

End-UserOutlook (Revenue, USD Million; 2017-2027)

Regional Outlook (Revenue, USD Million;2017-2027)

Have a Look at Similar Research Reports:

Laboratory Filtration Market- Filtration is a technique that is used to separate solids from liquids or solution by interposing a filter medium through which solutions or liquids can pass.

Virus Filtration Market - increasing emphasis and growing investment in R&D activities in the biotechnology sector, there has been an elevated demand for virus filtration.

Gene Expression Market - Gene expression is the method that refers to the process of measuring the activity of genes in order to comprehend the cellular functions.

In vivo CRO Market - Shifting of preference of pharmaceutical industries toward the outsourcing clinical and preclinical trials to focus on their core business, increasing frequency of outsourcing R&D activities.

Protein Engineering Market- Protein engineering is an emerging field that involves synthesis of new proteins as well as amendment in the existing protein structures that ultimately helps to achieve desired functions.

3D Cell Culture Market- The growth is mainly contributed by the government and non-government investments for cancer research & development, coupled with large scale end users for stem cell research.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:John WHead of Business DevelopmentReports And Data | Web: http://www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: [emailprotected] LinkedIn | Twitter | Blogs

Read full Press Release at :https://www.reportsanddata.com/press-release/global-sterile-filtration-market

SOURCE Reports And Data

See the original post:

Sterile Filtration Market To Reach USD 8.48 Billion By 2027 | CAGR: 7.7% | Reports And Data - PRNewswire

Read more
The Science of Survival: Evolving Research in Advanced Non-Small Cell Lung Cancer – Reuters

Despite significant progress in treating cancer in recent years, the need for further improvements has persisted particularly for some of the most challenging forms of the disease, such as lung cancer. Lung cancer is one of the most common cancers, and is the leading cause of cancer death in both men and women.

The majority of lung cancer cases are non-small cell lung cancer (NSCLC), a complex disease that can affect each patient differently. Most cases of NSCLC are not diagnosed until the disease is advanced meaning it has metastasized or spread which can make it more challenging to treat.

The impact of lung cancer, and advanced NSCLC in particular, continues to be felt across our communities, explained Andrea Ferris, president and chairman of LUNGevity Foundation. While every persons experience with the disease is unique, many patients hope they can retain a sense of normalcy in their lives and are seeking more treatment options that offer a chance at a longer life.

Research Driving New Progress for Certain Patients

Researchers have accelerated their pursuit of new and differentiated approaches that address this critical unmet need, focusing on options that may offer patients a chance at a longer life. One area of research that has shown potential is combining treatments, such as immunotherapies, for certain patients with previously untreated advanced disease.

Hossein Borghaei, D.O., chief of thoracic medical oncology at Fox Chase Cancer Center in Philadelphia explains, Progress in treating advanced lung cancer has led to more options for patients with newly diagnosed advanced NSCLC. Some of the most recent developments in the field of immunotherapy are particularly exciting.

One example is the U.S. Food and Drug Administrations approval of the first and only dual immunotherapy approach for newly diagnosed patients. Opdivo (nivolumab) is a prescription medicine used in combination with Yervoy (ipilimumab) for adults with advanced stage NSCLC that has spread to other parts of your body (metastatic) and tests positive for PD-L1 and do not have an abnormal EGFR or ALK gene.

Opdivo can cause problems that can sometimes become serious or life threatening and can lead to death. Serious side effects may include lung problems (pneumonitis); intestinal problems (colitis) that can lead to tears or holes in your intestine; liver problems (hepatitis); hormone gland problems (especially the thyroid, pituitary, adrenal glands, and pancreas); kidney problems, including nephritis and kidney failure; skin problems; inflammation of the brain (encephalitis); problems in other organs; and severe infusion reactions; and complications of stem-cell transplant that uses donor stem cells (allogeneic). Additional serious side effects of Yervoy alone include: nerve problems that can lead to paralysis; eye problems; and complications of stem-cell transplant that uses donor stem cells (allogeneic). Please see Important Facts about side effects for Opdivo and Yervoy below.

Opdivo and Yervoy work with your immune system to help fight cancer in two ways. Yervoy stimulates the kind of cells that help fight cancer, while Opdivo may help these cells to find and fight the cancer cells again. While doing so, Opdivo and Yervoy can also affect healthy cells. These problems can sometimes become serious or life threatening and can lead to death. These problems may happen anytime during treatment or even after treatment has ended. Some of these problems may happen more often when Opdivo is used in combination with Yervoy.

Clinical Trial Findings: A Chance to Live Longer

Opdivo + Yervoy was studied in a clinical trial and compared to platinum-based chemotherapy among certain patients with previously untreated, advanced NSCLC that tested positive for PD-L1.

In the trial, 396 patients received Opdivo + Yervoy and 397 patients received platinum-based chemotherapy. Patients who were treated with Opdivo + Yervoy lived longer than those treated with platinum-based chemotherapy:

In the trial, 396 patients received Opdivo + Yervoy and 397 patients received platinum-based chemotherapy. Patients who were treated with Opdivo + Yervoy lived longer than those treated with platinum-based chemotherapy:

An additional analysis showed:

The data supporting this dual immunotherapy approach are encouraging, particularly as one third of the patients who responded to treatment with Opdivo + Yervoy were still alive at three years, said Dr. Borghaei. Further, Opdivo + Yervoy offers a non-chemotherapy option, which can be important to some patients.

The most common side effects of Opdivo, when used in combination with Yervoy, include: feeling tired; diarrhea; rash; itching; nausea; pain in muscles, bones, and joints; fever; cough; decreased appetite; vomiting; stomach-area (abdominal) pain; shortness of breath; upper respiratory tract infection; headache; low thyroid hormone levels (hypothyroidism); decreased weight; and dizziness. Please see Important Facts about side effects for Opdivo and Yervoy below.

Evolving Outlooks and Adapting Support for Patients

Facing a lung cancer diagnosis and beginning treatment can be life-altering in many ways and todays unique environment as a result of the coronavirus has brought about additional considerations for patients, caregivers and the broader healthcare community, with telemedicine and other forms of remote support playing an increasingly vital role.

Patients should know there are resources available and ways to stay connected, even during times when maintaining physical distance from others is important, said Ferris. We have transformed many of our patient support and education offerings into virtual formats, which we are updating frequently to provide the most recent information and reach and connect as many people as possible.

Dr. Borghaei also urges patients to reach out to their doctor or care team to learn about and take advantage of available remote support offerings. Advances in cancer research are still happening every day, with Opdivo + Yervoy being one example. Its as important as ever that people diagnosed with lung cancer speak with their doctor to fully understand their treatment options. While how we deliver care might look different now in some ways, our commitment to helping patients live longer hasnt changed.

To learn more about Opdivo + Yervoy, please visit http://www.Opdivo.com.

INDICATION

OPDIVO (nivolumab) is a prescription medicine used in combination with YERVOY (ipilimumab) as a first treatment for adults with a type of advanced stage lung cancer (called non-small cell lung cancer) when your lung cancer has spread to other parts of your body (metastatic) and your tumors are positive for PD-L1, but do not have an abnormal EGFR or ALK gene.

It is not known if OPDIVO is safe and effective in children younger than 18 years of age.

OPDIVO (10 mg/mL) and YERVOY (5 mg/mL) are injections for intravenous (IV) use.

ImportantSafetyInformationforOPDIVO(nivolumab) + YERVOY (ipilimumab)

OPDIVO is a medicine that may treat certain cancers by working with your immune system. OPDIVO can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become serious or life-threatening and can lead to death. These problems may happen anytime during treatment or even after your treatment has ended. Some of these problems may happen more often when OPDIVO is used in combination with YERVOY.

YERVOY can cause serious side effects in many parts of your body which can lead to death. These problems may happen anytime during treatment with YERVOY or after you have completed treatment.

Serious side effects may include:Lung problems (pneumonitis). Symptoms of pneumonitis may include: new or worsening cough; chest pain; and shortness of breath. Intestinal problems (colitis) that can lead to tears or holes in your intestine. Signs and symptoms of colitis may include: diarrhea (loose stools) or more bowel movements than usual; blood in your stools or dark, tarry, sticky stools; and severe stomach area (abdomen) pain or tenderness. Liver problems (hepatitis). Signs and symptoms of hepatitis may include: yellowing of your skin or the whites of your eyes; severe nausea or vomiting; pain on the right side of your stomach area (abdomen); drowsiness; dark urine (tea colored); bleeding or bruising more easily than normal; feeling less hungry than usual; and decreased energy.Hormone gland problems (especially the thyroid, pituitary, adrenal glands, and pancreas). Signs and symptoms that your hormone glands are not working properly may include: headaches that will not go away or unusual headaches; extreme tiredness; weight gain or weight loss; dizziness or fainting; changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness; hair loss; feeling cold; constipation; voice gets deeper; and excessive thirst or lots of urine. Kidney problems, including nephritis and kidney failure.Signs of kidney problems may include: decrease in the amount of urine; blood in your urine; swelling in your ankles; and loss of appetite. Skin problems.Signs of these problems may include: rash; itching; skin blistering; and ulcers in the mouth or other mucous membranes. Inflammation of the brain (encephalitis). Signs and symptoms of encephalitis may include: headache; fever; tiredness or weakness; confusion; memory problems; sleepiness; seeing or hearing things that are not really there (hallucinations); seizures; and stiff neck. Problems in other organs. Signs of these problems may include: changes in eyesight; severe or persistent muscle or joint pains; severe muscle weakness; and chest pain.

Additional serious side effects observed during a separate study of YERVOY alone include: Nerve problems that can lead to paralysis. Symptoms of nerve problems may include: unusual weakness of legs, arms, or face; and numbness or tingling in hands or feet. Eye problems.Symptoms may include: blurry vision, double vision, or other vision problems; and eye pain or redness.

Get medical help immediatelyif you develop any of these symptoms or they get worse. It may keep these problems from becoming more serious. Your healthcare team will check you for side effects during treatment and may treat you with corticosteroid or hormone replacement medicines. If you have a serious side effect, your healthcare team may also need to delay or completely stop your treatment.

OPDIVO and OPDIVO + YERVOY can cause serious side effects, including: Severe infusion reactions. Tell your doctor or nurse right away if you get these symptoms during an infusion: chills or shaking; itching or rash; flushing; difficulty breathing; dizziness; fever; and feeling like passing out.Graft-versus-host disease, a complication that can happen after receiving a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic), may be severe, and can lead to death, if you receive YERVOY either before or after transplant. Your healthcare provider will monitor you for the following signs and symptoms: skin rash, liver inflammation, stomach-area (abdominal) pain, and diarrhea.

Pregnancy and Nursing: Tell your healthcare provider if you are pregnant or plan to become pregnant. OPDIVO and YERVOY can harm your unborn baby. If you are a female who is able to become pregnant, your healthcare provider should do a pregnancy test before you start receiving OPDIVO. Females who are able to become pregnant should use an effective method of birth control duringtreatmentand for at least 5 months after the last dose. Talk to your healthcare provider about birth control methods that you can use during this time. Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment. You or your healthcare provider should contact Bristol Myers Squibb at 1-800-721-5072 as soon as you become aware of the pregnancy. Pregnancy Safety Surveillance Study: Females who become pregnant during treatment with YERVOY are encouraged to enroll in a Pregnancy Safety Surveillance Study. The purpose of this study is to collect information about the health of you and your baby. You or your healthcare provider can enroll in the Pregnancy Safety Surveillance Study by calling 1-844-593-7869. Before receiving treatment, tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if either treatment passes into your breast milk. Do not breastfeed during treatment and for 5 months after the last dose.

Tell your healthcare provider about: Your health problems or concerns if you: have immune system problems such as autoimmune disease, Crohns disease, ulcerative colitis, lupus, or sarcoidosis; have had an organ transplant; have lung or breathing problems; have liver problems; or have any other medical conditions. All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

The most common side effects of OPDIVO, when used in combination with YERVOY, include: feeling tired; diarrhea; rash; itching; nausea; pain in muscles, bones, and joints; fever; cough; decreased appetite; vomiting; stomach-area (abdominal) pain; shortness of breath; upper respiratory tract infection;headache; low thyroid hormone levels (hypothyroidism); decreased weight; and dizziness.

These are not all the possible side effects. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatchor call 1-800-FDA-1088.

Please see U.S. Full Prescribing Information and Medication Guide forOPDIVO and YERVOY.

2020 Bristol-Myers Squibb Company.

OPDIVO and YERVOY are registered trademarks of Bristol-Myers Squibb Company.

7356US2001251-01 08/20

Excerpt from:

The Science of Survival: Evolving Research in Advanced Non-Small Cell Lung Cancer - Reuters

Read more
Stem Cell Antibody Market Demand Analysis and Projected huge Growth by 2025 – Scientect

Up Market Research (UMR) has published a latest market research report on Global Stem Cell Antibody Market. The global report is prepared in collaboration with the leading industry experts and dedicated research analyst team to provide an enterprise with in-depth market insights and help them to take crucial business decisions. This report covers current market trends, opportunities, challenges, and detailed competitive analysis of the industry players in the market.

The published report explains about the current supply and demand scenario and presents the future outlook of the market in a detailed manner. Up Market Research (UMR) has applied a robust market research methodology to bestow the new entrants and emerging players with 360 wide-view analysis on the latest advancements and their impacts on the market. It has congregated massive amount of data on the key segments of the market in an easy to understand format. The research report has laid out the numbers and figures in a comprehensive manner with the help of graphical and pictorial representation which embodies more clarity on the market.

You can buy this complete report @ https://www.upmarketresearch.com/buy/stem-cell-antibody-market

Report Covers Impacts of COVID-19 to the market.

The on-going pandemic has overhauled various facets of the market. This research report provides the financial impacts and market disturbance on the Stem Cell Antibody market. It also includes analysis on the potential lucrative opportunities and challenges in the foreseeable future. Up Market Research (UMR) has interviewed various delegates of the industry and got involved in the primary and secondary research to confer the clients with information and strategies to fight against the market challenges amidst and after COVID-19 pandemic.

Market Segmentation:

Few of the companies that are covered in the report.

Thermo Fisher Scientific Inc. (U.S.)Merck Group (Germany) Abcam plc (U.K.)Becton Dickinson and Company (U.S.)Bio-Rad Laboratories Inc. (U.S.)Cell Signaling Technology Inc. (U.S.)Agilent Technologies Inc. (U.S.)F. Hoffmann-La Roche Ltd (Switzerland)Danaher Corporation (U.S.)GenScript (U.S.) PerkinElmer Inc. (U.S.)Lonza (Switzerland) and BioLegend Inc. (U.S.)

Note: Additional companies can be included in the list upon the request.

By Product Type:

Primary AntibodiesSecondary Antibodies

By Applications:

ProteomicsDrug DevelopmentGenomics

By Geographical Location:Asia Pacific: China, Japan, India, and Rest of Asia PacificEurope: Germany, the UK, France, and Rest of EuropeNorth America: The US, Mexico, and CanadaLatin America: Brazil and Rest of Latin AmericaMiddle East & Africa: GCC Countries and Rest of Middle East & Africa

Exclusive Free Sample Report @ https://www.upmarketresearch.com/home/requested_sample/51767

The research report provides a detailed analysis of the prominent player in the market, products, applications, and regional analysis which also include impacts of government policies in the market. Moreover, you can sign up for the yearly updates on the Stem Cell Antibody market.

7 Reasons for Buying Stem Cell Antibody Market Report

If you have any query regarding the report, ask our experts: @ https://www.upmarketresearch.com/home/enquiry_before_buying/51767

Below is the TOC of the report:

About Up Market Research (UMR)

Up Market Research (UMR) has an extensive experience in the creation of tailored market research reports in several industry verticals. We cover in-depth market analysis which include producing creative business strategies for the new entrants and the emerging players of the market. We take care that our every report goes through intensive primary, secondary research, interviews, and consumer surveys. Our company provide market threat analysis, market opportunity analysis, and deep insights on the current and market scenario.

To provide the utmost quality of report, we invest in analysts that holds stellar experience in business domain and has excellent analytical and communication skills. Our dedicated team goes through quarterly training which helps them to acknowledge the latest industry practices and to serve the clients with foremost consumer experience.

Contact Info UpMarketResearchName Alex MathewsEmail [emailprotected]Website https://www.upmarketresearch.comAddress 500 East E Street, Ontario, CA 91764, United States.

Read the original post:

Stem Cell Antibody Market Demand Analysis and Projected huge Growth by 2025 - Scientect

Read more
Expression Therapeutics Announces Success in Developing a Stem Cell Lentiviral Gene Therapy for Hemophagocytic Lymphohistiocytosis (HLH) – PRNewswire

ATLANTA, Aug. 24, 2020 /PRNewswire/ -- Primary HLH is a family of devastating primary immune deficiencies with limited treatment options and no gene therapies under clinical testing. Expression Therapeutics has developed a promising and potentially curative gene therapy candidate for familial hemophagocytic lymphohistiocytosis (HLH) type 3 (FHL3). Untreated, FHL3 presents as a hyper-inflammatory state with multi-organ damage leading to premature death. Expression Therapeutics expects to rapidly progress candidates for other common forms of primary HLH as well.

"We are excited to announce this expansion of our gene and cell therapy pipeline beyond our lead stem cell lentiviral gene therapy candidate for hemophilia A that is entering Phase 1 clinical testing. Through ongoing research and development incorporating our core technology platforms, Expression Therapeutics has been able to rapidly generate promising therapeutic candidates for our HLH portfolio and several other critical disease areas with significant unmet clinical need," said Christopher Doering, Ph.D., Chief Scientific Officer of Expression Therapeutics.

Proof of concept for stem cell lentiviral gene therapy of FHL3 was demonstrated using primary patient cells and a genetic mouse model of FHL3. A key component in this success was the integration of one of Expression Therapeutics' core technology platforms that facilitates the rapid generation of transgenes with superior potency. Our lead candidate successfully restored exocytosis and cytolytic function to primary patient cells as well as a murine disease model strongly supporting the advancement of this pipeline product candidate.

"We believe there are three key aspects to FHL3 that make it a strong candidate for hematopoietic stem and progenitor cell (HSPC) lentiviral vector (LV) gene therapy. First, preclinical and clinical studies suggest that less than 20% genetically corrected cells are required to reverse most FHL3 disease symptoms. Second, because of the autologous nature of stem cell-based lentiviral gene therapy, the grave risk of graft vs host disease is eliminated. Third, with stem cell-based lentiviral gene therapy there will be no wait time to find a sufficiently human leukocyte antigen-matched donor," said Trent Spencer, Ph.D., President of Expression Therapeutics.

According to Deanna Fournier, Executive Director of the Histiocytosis Association, "We are very excited about the possibilities this work offers. Our HLH community, and the entire histiocytosis community, is very hopeful and excited about the future!"

Expression Therapeutics is a biotechnology company based in Atlanta and Cincinnati. The current therapeutic pipeline includes advanced gene therapies for hemophilia, neuroblastoma, T-cell leukemia/lymphoma, acute myeloid leukemia (AML), and primary immunodeficiencies such as hemophagocytic lymphohistiocytosis (HLH).

For inquiries, please contact:

Ashley WalshDirector of Corporate DevelopmentExpression Therapeutics 1860 Montreal RoadTucker, Georgia 30084[emailprotected]+1 312.637.2975www.expressiontherapeutics.com

SOURCE Expression Therapeutics

http://www.expressiontherapeutics.com

Continued here:

Expression Therapeutics Announces Success in Developing a Stem Cell Lentiviral Gene Therapy for Hemophagocytic Lymphohistiocytosis (HLH) - PRNewswire

Read more